Market/Novel Tech

A UK gene therapy company (MeiraGTx) has announced positive clinical data for the treatment of X-linked retinitis pigmentosa (XLRP)

MeiraGTx (Nasdaq: MGTX), has announced six-month data from an ongoing phase 1/2 clinical trial of AAV-RPGR for the treatment of patients with X-linked retinitis pigmentosa (XLRP).… Read More »A UK gene therapy company (MeiraGTx) has announced positive clinical data for the treatment of X-linked retinitis pigmentosa (XLRP)

Applied Genetic Technologies Corporation (NASDAQ: AGTC; Florida, USA) announced the publication of positive preclinical data for X-linked retinitis pigmentosa

Applied Genetic Technologies Corporation Inc. (Nasdaq: AGTC) has announced the publication of positive preclinical data for X-linked retinitis pigmentosa.  The research study, entitled, “Dose Range Finding… Read More »Applied Genetic Technologies Corporation (NASDAQ: AGTC; Florida, USA) announced the publication of positive preclinical data for X-linked retinitis pigmentosa